Peptide receptor radionuclide therapy (PRRT)

Peptide receptor radionuclide therapy (PRRT) - How to prevent?

Peptide receptor radionuclide therapy (PRRT) - Causes and Risk Factors

Peptide receptor radionuclide therapy (PRRT) - Treatments

Peptide receptor radionuclide therapy (PRRT) - Preparing for surgery

Blood tests looking at the blood counts, kidney function and liver function are needed before proceeding with PRRT. A Gallium-68 dotapeptide PET/CT scan is also done beforehand to determine if the tumour expresses somatostatin receptors and PRRT is a suitable treatment.

PRRT is administered intravenously. A short hospital stay in the radiation isolation room is required to monitor patients during and after the infusion of the radiopharmaceutical. Scans will be performed the day after to see the distribution of the radiopharmaceutical.

Peptide receptor radionuclide therapy (PRRT) - Other Information

Neuroendocrine Tumors

Article contributed by Nuclear Medicine and Molecular Imaging, Singapore General Hospital

The information provided is not intended as medical advice. Terms of use. Information provided by SingHealth

TOP

Discover articles,videos, and guides afrom Singhealth's resources across the web. These information are collated, making healthy living much easier for everyone.